8 months ago
PODD
AnalystsMarie ThibaultMarie Thibault's Stock Forecasts
AnalystsMarie Thibault
Analyst Ranking
Top 14%
#683 out of 4923 analysts
Average Return
+10.97%
Win Rate
51%40 out of 78
Risk vs Reward
Poor
Good
Marie Thibault's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Senseonics Holdings IncSENS | +510.90% | $0.53 | $3.25 | 2020-08-11 - 2021-08-09 | Strong Buy |
Sitime CorpSITM | +374.27% | $21.03 | $99.74 | 2020-04-09 - 2021-04-09 | Strong Buy |
Establishment Labs Holdings IncESTA | +308.57% | $14.58 | $59.57 | 2020-03-17 - 2021-03-17 | Strong Buy |
Accuray IncARAY | +77.18% | $2.06 | $3.65 | 2022-06-24 - 2023-06-23 | Strong Buy |
Insulet CorpPODD | +72.45% | $182.19 | $314.18 | 2024-08-09 - 2025-06-30 | Strong Buy |
Marie Thibault Analyst Color
Get additional color on Marie Thibault's coverage of popular stocks
9 months ago
MASI
9 months ago
PODD
9 months ago
ESTA
9 months ago
BSX
a year ago
BSX
2 years ago
BSX
2 years ago
DCTH
2 years ago
DXCM
2 years ago
DXCM
2 years ago
IRTC
2 years ago
ESTA
2 years ago
DXCM
2 years ago
BSX
3 years ago
DXCM
3 years ago
ESTA
3 years ago
BSX
3 years ago
ESTA
Marie Thibault's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Atricure IncATRC | 7 | Strong Buy | $52.00 | +58.68% | Maintains | 2 months ago |
Orchestra Biomed Holdings IncOBIO | 1 | Strong Buy | $12.00 | +347.76% | Initiates Coverage On | 3 months ago |
Embecta CorpEMBC | 2 | Strong Buy | $26.00 | +168.32% | Upgrades | 7 months ago |
Insulet CorpPODD | 4 | Strong Buy | $270.00 | -14.06% | Maintains | 8 months ago |
Masimo CorpMASI | 3 | Strong Buy | $170.00 | +1.06% | Maintains | 9 months ago |
Establishment Labs Holdings IncESTA | 7 | Strong Buy | $65.00 | +52.19% | Maintains | 9 months ago |
Boston Scientific CorpBSX | 7 | Strong Buy | $93.00 | -13.42% | Maintains | 9 months ago |
Haemonetics CorpHAE | 1 | Strong Buy | $112.00 | +50.11% | Initiates Coverage On | 10 months ago |
Dexcom IncDXCM | 7 | Strong Buy | $120.00 | +37.47% | Maintains | a year ago |
Outset Medical IncOM | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | a year ago |
Delcath Systems IncDCTH | 2 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Beyond Air IncXAIR | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Irhythm Technologies IncIRTC | 7 | Strong Buy | $140.00 | N/A | Maintains | 2 years ago |
Icad IncICAD | 3 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Abbott LaboratoriesABT | 9 | Strong Buy | $125.00 | N/A | Maintains | 2 years ago |
Inari Medical IncNARI | 3 | Strong Buy | $97.00 | N/A | Maintains | 3 years ago |
Pear Therapeutics IncPEARQ | 3 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Vapotherm IncVAPO | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Viewray IncVRAYQ | 3 | Strong Buy | $8.00 | N/A | Maintains | 3 years ago |
Venus Concept IncVERO | 2 | Strong Buy | $907.50 | N/A | Maintains | 3 years ago |
Acutus Medical IncAFIB | 3 | Strong Buy | $1.50 | N/A | Maintains | 3 years ago |
Accuray IncARAY | 2 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Neuronetics IncSTIM | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Senseonics Holdings IncSENS | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Varian Medical Systems IncVAR | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Sitime CorpSITM | 1 | Strong Buy | $6.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.